In conclusions, we found miR-21-5p and miR-23a-3p were both downregulated in treatment-naive severe OSA patients, while TNF-α was upregulated, with all these three gene expressions being correlated well with disease severity. The gene discussed is TNF; the disease is obstructive sleep apnea syndrome.